Gut microbiota and ovarian diseases: a new therapeutic perspective

被引：0

作者：

Shan Ju ^{[1
]}

Zhen Yang Kang ^{[2
]}

Li Ya Yang ^{[3
]}

Yong Jun Xia ^{[3
]}

Yi Ming Guo ^{[1
]}

Sui Li ^{[2
]}

Hongli Yan ^{[3
]}

Ming Kang Qi ^{[1
]}

Hui Ping Wang ^{[4
]}

Lian Zhong ^{[2
]}

机构：

[1] University of Shanghai for Science and Technology,School of Health Science and Engineering, Shanghai Engineering Research Center of Food Microbiology

[2] Chinese Academy of Medical Sciences,Graduate School of Peking Union Medical College

[3] National Research Institute for Family Planning,NHC Key Laboratory of Reproductive Health Engineering Technology Research (NRIFP)

[4] Changhai hospital,undefined

[5] the Navy medical university,undefined

来源：

Journal of Ovarian Research | / 18卷 / 1期

关键词：

Gut microbiota; Premature ovarian insufficiency; Polycystic ovary syndrome; Ovarian tumors;

D O I：

10.1186/s13048-025-01684-5

中图分类号：

学科分类号：

摘要：

The gut microbiota is a complex community of microorganisms that inhabit the human gastrointestinal tract, helping to maintain the ecological balance of the body’s internal and external environments. Disruptions in the composition and diversity of gut microbiota, as well as changes in their metabolic functions, can link to the development and severity of conditions such as premature ovarian insufficiency, polycystic ovary syndrome, and ovarian tumors. This article thoroughly reviews recent research on the connection between gut microbiota and ovarian diseases, providing fresh perspectives on their prevention, pathogenesis, and treatment.

引用

共 50 条

[1] Gut microbiota in pancreatic diseases: possible new therapeutic strategies
Li-long Pan
Bin-bin Li
Xiao-hua Pan
Jia Sun
Acta Pharmacologica Sinica, 2021, 42 : 1027 - 1039
[2] Gut microbiota in pancreatic diseases: possible new therapeutic strategies
Pan, Li-long
Li, Bin-bin
Pan, Xiao-hua
Sun, Jia
ACTA PHARMACOLOGICA SINICA, 2021, 42 (07) : 1027 - 1039
[3] Gut Microbiota in Autophagy Regulation: New Therapeutic Perspective in Neurodegeneration
Mitra, Sarmistha
Munni, Yeasmin Akter
Dash, Raju
Sadhu, Toma
Barua, Largess
Islam, Md. Ariful
Chowdhury, Dipannita
Bhattacharjee, Debpriya
Mazumder, Kishor
Moon, Il Soo
LIFE-BASEL, 2023, 13 (04):
[4] The gut microbiota: A new perspective for tertiary prevention of hepatobiliary and gallbladder diseases
Huang, Xiaoyu
Yang, Yi
Li, Xueli
Zhu, Xiaoya
Lin, Dan
Ma, Yueran
Zhou, Min
Cui, Xiangyi
Zhang, Bingyu
Dang, Dongmei
Lu, Yuhong
Yue, Changwu
FRONTIERS IN NUTRITION, 2023, 10
[5] New Insights into the Gut Microbiota in Neurodegenerative Diseases from the Perspective of Redox Homeostasis
Wang, Yu
Zhang, Zhe
Li, Bowen
He, Bo
Li, Lei
Nice, Edouard C.
Zhang, Wei
Xu, Jia
ANTIOXIDANTS, 2022, 11 (11)
[6] Gut microbiota in gastrointestinal diseases: Insights and therapeutic strategies
Jiang, Lu
Fan, Jian-Gao
WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (39) : 4329 - 4332
[7] Gut microbiota: a new insight into neurological diseases
Liu Lanxiang
Wang Haiyang
Chen Xueyi
Xie Peng
中华医学杂志英文版, 2023, 136 (11)
[8] Gut microbiota: A new insight into lung diseases
Ma, Pei-Jun
Wang, Meng-Meng
Wang, Yun
BIOMEDICINE & PHARMACOTHERAPY, 2022, 155
[9] Gut microbiota: a new insight into neurological diseases
Liu, Lanxiang
Wang, Haiyang
Chen, Xueyi
Xie, Peng
CHINESE MEDICAL JOURNAL, 2023, 136 (11) : 1261 - 1277
[10] Bioavailability Based on the Gut Microbiota: a New Perspective
Zhang, Feng
He, Fang
Li, Li
Guo, Lichun
Zhang, Bin
Yu, Shuhuai
Zhao, Wei
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2020, 84 (02)

← 1 2 3 4 5 →